Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Dyne Therapeutics Inc., 3 years.
Dyne Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Dyne Therapeutics Inc. | Open-market sale | −256,072 | $25.50 | $6,530,451 |
| Jul 27, 2026 | Dyne Therapeutics Inc. | Open-market sale | −5,388 | $26.04 | $140,319 |
| Jun 23, 2026 | Dyne Therapeutics Inc. | Open-market sale | −71,629 | $21.04 | $1,507,074 |
| Jun 23, 2026 | Dyne Therapeutics Inc. | Open-market sale | −1,657 | $21.47 | $35,576 |
| Jun 22, 2026 | Dyne Therapeutics Inc. | Open-market sale | −190,676 | $20.57 | $3,922,205 |
| Jun 18, 2026 | Dyne Therapeutics Inc. | Open-market sale | −46,901 | $20.07 | $941,303 |
| Jun 17, 2026 | Dyne Therapeutics Inc. | Open-market sale | −37,454 | $20.14 | $754,324 |
| Apr 22, 2026 | Dyne Therapeutics Inc. | Open-market sale | −2,652 | $20.00 | $53,040 |
| Apr 21, 2026 | Dyne Therapeutics Inc. | Open-market sale | −8,300 | $20.01 | $166,083 |
| Apr 20, 2026 | Dyne Therapeutics Inc. | Open-market sale | −125,274 | $20.07 | $2,514,249 |
| Apr 17, 2026 | Dyne Therapeutics Inc. | Open-market sale | −211,974 | $20.29 | $4,300,952 |
| Apr 16, 2026 | Dyne Therapeutics Inc. | Open-market sale | −11,116 | $21.10 | $234,548 |
| Apr 16, 2026 | Dyne Therapeutics Inc. | Open-market sale | −6,657 | $20.06 | $133,539 |
| Apr 15, 2026 | Dyne Therapeutics Inc. | Open-market sale | −81,840 | $20.27 | $1,658,897 |
| Mar 11, 2026 | Dyne Therapeutics Inc. | Open-market sale | −129,672 | $19.52 | $2,531,197 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.